WASHINGTON, April 18, 2018 /PRNewswire/ --áVanda Pharmaceuticals Inc.(Vanda) (NASDAQ: VNDA) today announced it will release results for the first quarter of 2018 on Wednesday, May 2, 2018, after the market closes.
Vanda will host a conference call at 4:30 PM
The conference call will be broadcast simultaneously and archived on Vanda's website, www.vandapharma.com. Investors should go to the website at least 15 minutes early to register, download, and install any necessary audio software.
A replay of the call will be available on Wednesday, May 2, 2018, beginning at 7:00 PM ET and will be accessible until Wednesday, May 9, 2018, at 11:59 PM ET. The replay call-in number is 1-888-843-7419 for domestic callers and 1-630-652-3042 for international callers. áThe passcode number is 46823596.
ABOUT VANDA PHARMACEUTICALS INC.: Vanda is a global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com.
Investor Contact: Jim KellyExecutive Vice President & Chief Financial OfficerVanda Pharmaceuticals Inc.(202) firstname.lastname@example.org
View original content:http://www.prnewswire.com/news-releases/vanda-pharmaceuticals-to-announce-first-quarter-2018-financial-results-on-may-2-2018-300632344.html
SOURCE Vanda Pharmaceuticals Inc.
Subscribe to our Free Newsletters!
Osteolysis refers to breaking down of bone tissue. Bone loss occurs due to resorption of bone by ...
Patisiran injection, recently approved by FDA to treat polyneuropathy, a disease that causes ...
Dysgraphia or disorder of written expression is a childhood learning disorder marked by poor ...View All